Contextlogic Holdings Inc. (LOGC) Stock Price & Analysis
Contextlogic Holdings Inc. (LOGC) fell 0.21% to USD 9.35 as of July 25, 2026 at 03:08 UTC, according to Nexqual real-time market data.
LOGC last closed at USD 9.37; the session ranged USD 9.31–9.7 on volume of 41,681 shares. Market capitalization is $427.58M, with a 52-week range of USD 7.05–10.35 (OQB). Source: Nexqual, July 25, 2026 at 03:08 UTC.
Key Statistics (as of July 25, 2026 at 03:08 UTC)
| Price | USD 9.35 |
|---|---|
| Change | ▼ 0.21% (down) |
| Previous Close | USD 9.37 |
| Open | USD 9.31 |
| Day Range | USD 9.31 – 9.7 |
| 52-Week Range | USD 7.05 – 10.35 |
| Volume | 41,681 shares |
| Market Cap | $427.58M |
| Exchange | OQB |
Technical Analysis (LOGC)
Nexqual's technical model rates LOGC "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 03:08 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 56.89 (neutral) |
| vs SMA50 | Above (USD 9.08) |
| MACD | 0.07 (positive) |
Analyst Ratings (LOGC)
Wall Street analysts rate LOGC "None", per Nexqual as of July 25, 2026 at 03:08 UTC.
| Consensus Rating | None |
|---|
Earnings (LOGC)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-03-31 | USD -0.27 vs est -0.08 ▼ miss |
| 2024-12-31 | USD -0.08 vs est 0.04 ▼ miss |
| 2024-09-30 | USD -0.04 vs est -0.01 ▼ miss |
Source: Nexqual, July 25, 2026 at 03:08 UTC.
Financials & Fundamentals (LOGC)
| Total Revenue | $100,000 |
|---|---|
| Revenue Growth (YoY) | +0.30% |
| Gross Margin | +0.00% |
| Operating Margin | +2.16% |
| Profit Margin | +0.00% |
| ROE | -1.85% |
| Debt / Equity | 28.71 |
| Current Ratio | 1.67 |
| Total Cash | $12.00M |
| Total Debt | $212.90M |
| Free Cash Flow | $-18.43M |
Source: Nexqual, July 25, 2026 at 03:08 UTC.
Financial Health Score (LOGC)
Nexqual rates Contextlogic Holdings Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 03:08 UTC.
| Growth | Critical — Revenue -85% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Strong — $12M cash vs $213M debt |
| Cash Flow | Weak — FCF negative: -$18M, burning cash |
| Efficiency | Critical — ROE -2%, ROA -4.0% |
Ownership (LOGC)
| Insider Ownership | +2.73% |
|---|---|
| Institutional Ownership | +45.30% |
| Shares Outstanding | 45.73M |
| Float | 25.87M |
| Short % of Float | +8.45% |
Source: Nexqual, July 25, 2026 at 03:08 UTC.
Leadership (LOGC)
Contextlogic Holdings Inc. is led by Mark Ward (age 30), President & Director, per Nexqual as of July 25, 2026 at 03:08 UTC.
| President & Director | Mark Ward (age 30) |
|---|---|
| CFO & COO | Scott Matthew Stewart C.F.A. (age 52) |
| Vice President of Investments | Janak Goyani |
Major Backers & Investors (LOGC)
Notable institutional backers of Contextlogic Holdings Inc. include American Century ETF Trust-Avantis U.S. Small Cap Equity ETF, according to Nexqual as of July 25, 2026 at 03:08 UTC.
Active Investors
| Investor | Stake |
|---|---|
| American Century ETF Trust-Avantis U.S. Small Cap Equity ETF | 0.11% |
Source: Nexqual, July 25, 2026 at 03:08 UTC.
From Contextlogic Holdings Inc.'s Latest SEC 10-K Filing (filed 2026-03-05)
Key Strengths & Strategy (as disclosed to the SEC)
- ContextLogic Holdings Inc. focuses on seeking to develop and grow a de novo business and finance potential future bolt-on acquisitions of assets or businesses.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KLDO | Kaleido Biosciences, Inc. | USD 0 | ▲ 0% |
| DTIL | Precision BioSciences, Inc. | USD 7.29 | ▼ 0.41% |
| GOSS | Gossamer Bio, Inc. | USD 0.14 | ▼ 6.21% |
| ALEC | Alector, Inc. | USD 1.48 | ▼ 3.27% |
| SPRO | Spero Therapeutics, Inc. | USD 1.19 | ▼ 6.3% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:08 UTC. This page is informational and not investment advice.